Recombinomics | Elegant Evolution






Home Founder What's New In The News Contact Us





























Paradigm Shift

Viral Evolution

Intervention Monitoring

Vaccine Screening

Vaccine Development

Expression Profiling

Drug Discovery

Custom Therapies

Patents



Audio:  Apr21  Sep22   Nov10  Jan19  RSS Feed     News Now                         

Commentary

Panasonic Families Head Back to Japan on Pandemic Concerns Recombinomics Commentary 03:30
February 10, 2009

Panasonic Corp. has instructed Japanese workers assigned to parts of Asia, Africa, Eastern Europe and South America to send family members back to Japan because of the risk of outbreaks of new influenza strains

The above comments indicate Panasonic is taking the looming pandemic seriously.  Most countries have stockpiled vaccines that will have little use after a pandemic begins, which is also true of Tamiflu.  In contrast, Japan has plans to use its 20 million doses of vaccine for the implementation of a pre-pandemic vaccination campaign that will involve first responders and may significantly expand into the general population.

Many countries have stockpiled clade 1 vaccines, which are nearing expiration and will have little utility after a pandemic begins.  Several studies have demonstrated the utility of use of these early vaccines as primers for booster shots using a vaccine target more closely related to current H54N1 clades in circulation such as clade 2 or clade 7.

Similarly, the fixing of H274Y in seasonal flu will likely lead to rapid resistance in H5N1 when transmission efficiencies improve or acquisition is driven by Tamiflu blankets applied to current smaller outbreaks in China, Indonesia, and Egypt.

Media Links

Recombinomics Presentations

Recombinomics Publications

Recombinomics Paper at Nature Precedings
















Home | Founder | What's New | In The News | Contact Us

Webmaster: webmaster@recombinomics.com
© 2009 Recombinomics.  All rights reserved.